Subscribe
Webinars
White Papers
Buyer's Guide
PhotonicsNXT
Get Published!
Lasers/Sources
Detectors/Imaging
Optics
Bio & Life Sciences
Laser Processing
Test/Measurement
Science & Research
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
BioOptics Stock Watch
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Latest News about AbbVie Inc
Recent news which mentions AbbVie Inc
Wednesday's big stock stories: What’s likely to move the market in the next trading session
October 29, 2024
Tags
Microsoft Corp
KB Home
Trump Media & Technology Group Corp
From
CNBC.com News
Cramer's Lightning Round: Sweetgreen is 'terrific'
October 16, 2024
Tags
Oracle Corp
Core Scientific Inc
Mad Money
From
CNBC.com News
Friday's big stock stories: What’s likely to move the market in the next trading session
August 22, 2024
Tags
Eli Lilly and Co
Equity Residential
Aflac Inc
From
CNBC.com News
Biden administration to release prices for first 10 drugs subject to landmark Medicare negotiations
August 15, 2024
Tags
Health & Science
Business News
US: News
From
CNBC.com News
Healthy Returns: What drugmakers are saying about final negotiated prices with Medicare
August 06, 2024
Tags
Politics
Biotech and Pharmaceuticals
Pfizer Inc
From
CNBC.com News
Healthy Returns: Sales of Humira are plunging, but AbbVie has two promising successors
May 01, 2024
Tags
Teva Pharmaceutical Industries Ltd
Biotech and Pharmaceuticals
Health & Science
From
CNBC.com News
AbbVie taps longtime executive Robert Michael as new CEO, succeeding Richard Gonzalez
February 20, 2024
Tags
Biotech and Pharmaceuticals
Health care industry
Biotechnology
From
CNBC.com News
After 8 months stuck in orbit, Varda's drug spacecraft gets FAA approval to return
February 14, 2024
Tags
Business
Aerospace and defense industry
Abbvie Inc
From
CNBC.com News
Cramer's Lightning Round: AbbVie is 'a very good company'
February 08, 2024
Tags
Investment strategy
Stock Picks
Market Outlook
From
CNBC.com News
Big pharma is at a crossroads, as J&J, Merck and others prepare to lose heaps of revenue from blockbuster drugs
January 28, 2024
Tags
Alvotech SA
Karuna Therapeutics Inc
Johnson & Johnson
From
CNBC.com News
J&J to acquire cancer drug developer Ambrx Biopharma for $2 billion
January 08, 2024
Tags
Biotechnology
Companies
US: News
From
CNBC.com News
Cramer names biopharma companies to watch as industry mergers start to pile up
January 05, 2024
Tags
AstraZeneca PLC
U/S/ Markets
ImmunoGen Inc
From
CNBC.com News
Pfizer shares fall as 2024 revenue and profit forecast disappoints
December 13, 2023
Tags
BioNTech SE
US: News
Moderna Inc
From
CNBC.com News
5 things to know before the stock market opens Thursday
December 07, 2023
Tags
Business
Walmart Inc
5 Things to Know
From
CNBC.com News
AbbVie to acquire neuroscience drugmaker Cerevel Therapeutics for $8.7 billion
December 06, 2023
Tags
Cerevel Therapeutics Holdings Inc
Health care industry
Biotech and Pharmaceuticals
From
CNBC.com News
Biotech stocks jump on AbbVie deal to buy cancer drugmaker ImmunoGen for $10 billion
November 30, 2023
Tags
Pfizer Inc
Merck & Co Inc
Biotech and Pharmaceuticals
From
CNBC.com News
Here are 16 stocks Jim Cramer is watching, including Microsoft, Chevron, Southwest
October 30, 2023
Tags
Breaking News: Markets
Abbvie Inc
Cisco Systems Inc
From
CNBC.com News
Cramer's Lightning Round: Energy Transfer is a buy
October 13, 2023
Tags
Business News
U/S/ Markets
Investing
From
CNBC.com News
Drugmakers opt in to Medicare drug price negotiations – here's what happens next
October 02, 2023
Tags
Health & Science
Business News
Companies
From
CNBC.com News
Federal judge declines to block Medicare price negotiations
September 29, 2023
Tags
Lawsuits
Breaking news
Business
From
CNBC.com News
Medicare drug price negotiations may have a muted impact on drugmakers in the near term
August 30, 2023
Tags
Business News
Health & Science
Biotechnology
From
CNBC.com News
CVS pushes further into generic drugs with Sandoz partnership for new discount Humira
August 23, 2023
Tags
Amgen Inc
CVS Health Corp
Novartis AG
From
CNBC.com News
These 10 medications are likely targets for Medicare price negotiations this fall
August 10, 2023
Tags
Business
Astellas Pharma Inc
Abbvie Inc
From
CNBC.com News
Hepatitis C cure is not reaching overwhelming majority of patients due to financial barriers
June 29, 2023
Tags
Health care industry
U/S/ Economy
Policy
From
CNBC.com News
Cramer's Lightning Round: Get rid of ADT
June 22, 2023
Tags
ADT Inc
Evergy Inc
Investment strategy
From
CNBC.com News
Drugmakers aim to strike down Medicare drug-price negotiations at Supreme Court
June 20, 2023
Tags
Breaking News: Business
Biotechnology
AstraZeneca PLC
From
CNBC.com News
GOP law cut Big Pharma tax rates by 40%, Senate report says
May 11, 2023
Tickers
LAW
LAWS
Tags
US: News
Companies
Law and Regulation
From
CNBC.com News
Stocks making the biggest moves midday: Honeywell, Caterpillar, Meta, First Republic & more
April 27, 2023
Tags
Hasbro Inc
eBay Inc
Market Insider
From
CNBC.com News
A Rotation Into Defensive Stocks? Market Strength Seen In Consumer Defensive And Healthcare On Tuesday
April 25, 2023
Tickers
ABBV
CNC
GIS
JNJ
Tags
pepsico
PEP
Market News
From
Benzinga
Biden administration will select first 10 drugs for Medicare price negotiations by September
January 11, 2023
Tags
Breaking News: Business
AstraZeneca PLC
Biotechnology
From
CNBC.com News
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.